Dapsone Tablet
Product Images NDC 70771-1979

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dapsone (NDC 70771-1979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 01)

This text contains information about Dapsone Tablets, USP with each tablet containing 25 mg of Dapsone. It advises to store the tablets at 20-25°C (66-77°F) and provides specific guidelines for temperature excursions. The packaging is child-resistant and recommends keeping the tablets in a light-resistant container and out of reach of children. It is manufactured by Zydus Pharmaceuticals Ltd. in Ahmedabad, India. Further dosage instructions are provided in accompanying literature.*

FDA Label Image

100 mg Label (A4ce6655 3e02 434d 87ad 5bcec90202c1 02)

This text provides information on Dapsone tablets, USP, containing 100 mg of Dapsone per tablet. The usual dosage should be referred to in the accompanying descriptive literature. The package is child-resistant and should be stored at 20°C to 25°C (66°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). It should be protected from light and dispensed in a tight, light-resistant container. The manufacturer is Zydus Pharmaceuticals Ltd. in Ahmedabad, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.